APP and Alzheimer disease: There is compelling evidence supporting an early and central role for Ca2+ dysregulation in the pathogenesis of Alzheimer’s disease (AD), including sporadic AD, whose etiology is not related to mutations in presenilins or APP (reviewed in [14,15,16,17]).